NASDAQ: ASNDAscendis Pharma A Stock Ownership - Who owns Ascendis Pharma A?
Insider buying vs selling
Have Ascendis Pharma A insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when ASND insiders and whales buy or sell their stock.
ASND Shareholders
What type of owners hold Ascendis Pharma A stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Ra Capital Management LP | 16.94% | 10,281,496 | $1.80B | Institution |
| Westfield Capital Management Co LP | 9.03% | 5,479,259 | $958.24M | Institution |
| Avoro Capital Advisors LLC | 8.60% | 5,218,000 | $912.55M | Institution |
| Fmr LLC | 7.70% | 4,672,943 | $817.23M | Institution |
| Janus Henderson Group PLC | 7.39% | 4,486,949 | $784.70M | Institution |
| Artisan Partners Limited Partnership | 7.01% | 4,256,627 | $744.42M | Institution |
| T Rowe Price Investment Management Inc | 5.03% | 3,053,824 | $534.07M | Institution |
| Capital International Investors | 4.74% | 2,874,792 | $502.76M | Institution |
| Price T Rowe Associates Inc | 3.72% | 2,256,102 | $394.56M | Institution |
| Morgan Stanley | 3.14% | 1,903,531 | $332.90M | Institution |
ASND vs Biotech Stocks
Ascendis Pharma A Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.